112 related articles for article (PubMed ID: 1486045)
21. Analysis of 66 patients definitive with transfusion-associated graft-versus-host disease and the effect of universal irradiation of blood.
Uchida S; Tadokoro K; Takahashi M; Yahagi H; Satake M; Juji T
Transfus Med; 2013 Dec; 23(6):416-22. PubMed ID: 24274074
[TBL] [Abstract][Full Text] [Related]
22. Broadening the spectrum of patient groups at risk for transfusion-associated GVHD: implications for universal irradiation of cellular blood components.
Anderson K
Transfusion; 2003 Dec; 43(12):1652-4. PubMed ID: 14641857
[No Abstract] [Full Text] [Related]
23. Association between HLA-B antigens and acute graft-versus-host disease.
Storb R; Prentice RL; Hansen JA; Thomas ED
Lancet; 1983 Oct; 2(8354):816-9. PubMed ID: 6137649
[TBL] [Abstract][Full Text] [Related]
24. Amplified fragment length polymorphism analysis in the evaluation of posttransfusion graft-versus-host disease in a child undergoing extracorporeal membrane oxygenation.
DePalma L; Bahrami KR; Kapur S; Short BL; Luban NL
J Thorac Cardiovasc Surg; 1994 Jul; 108(1):182-4. PubMed ID: 7913148
[No Abstract] [Full Text] [Related]
25. Transfusion of blood components to infants under four months: review and guidelines.
O'Riordan JM; Fitzgerald J; Smith OP; Bonnar J; Gorman WA;
Ir Med J; 2007 Jun; 100(6):suppl 1-24 following 496. PubMed ID: 17668683
[No Abstract] [Full Text] [Related]
26. [HLA typing in a neonate with posttransfusional graft vs host disease (PT-GVHD)].
Lista GL; Porcelli F; Mercuriali F; Farè M; Taccone F
Pediatr Med Chir; 1994; 16(3):285-7. PubMed ID: 7971455
[TBL] [Abstract][Full Text] [Related]
27. Transfusion-associated graft-versus-host disease in nonimmunocompromised hosts.
Vogelsang GB
Transfusion; 1990 Feb; 30(2):101-3. PubMed ID: 2137651
[No Abstract] [Full Text] [Related]
28. HLA homozygosity and shared HLA haplotypes in the development of transfusion-associated graft-versus-host disease.
Shivdasani RA; Anderson KC
Leuk Lymphoma; 1994 Oct; 15(3-4):227-34. PubMed ID: 7866271
[TBL] [Abstract][Full Text] [Related]
29. HLA-homozygous donors and transfusion-associated graft-versus-host disease.
N Engl J Med; 1990 Apr; 322(14):1004-7. PubMed ID: 2314438
[No Abstract] [Full Text] [Related]
30. Transfusion associated graft versus host disease.
Tipu HN; Ahmed TA; Khalilullah ; Ahmed S; Satti T; Ahmed P
J Pak Med Assoc; 2008 Mar; 58(3):143-5. PubMed ID: 18517122
[TBL] [Abstract][Full Text] [Related]
31. The role of blood from HLA-homozygous donors in fatal transfusion-associated graft-versus-host disease after open-heart surgery.
Thaler M; Shamiss A; Orgad S; Huszar M; Nussinovitch N; Meisel S; Gazit E; Lavee J; Smolinsky A
N Engl J Med; 1989 Jul; 321(1):25-8. PubMed ID: 2786605
[No Abstract] [Full Text] [Related]
32. Transfusion safety in 2012: main messages from the SHOT Annual Report for 2012.
Bolton-Maggs PH
Transfus Med; 2013 Aug; 23(4):217-8. PubMed ID: 23865394
[No Abstract] [Full Text] [Related]
33. Predictors of acute graft-versus-host disease in bone marrow transplantation between HLA-identical siblings.
Johnsen HE
N Engl J Med; 1993 May; 328(20):1497-8. PubMed ID: 8479479
[No Abstract] [Full Text] [Related]
34. Disseminated intravascular coagulation in transfusion-associated graft-versus-host disease. Report of two cases.
Murakawa M; Okamura T; Harada M; Esaki T; Kamura T; Shibuya T; Niho Y
Ann Clin Lab Sci; 1995; 25(1):31-8. PubMed ID: 7762966
[TBL] [Abstract][Full Text] [Related]
35. Preventing transfusion-associated graft-versus-host disease with blood component irradiation: indispensable guidance for a deadly disorder.
Ní Loingsigh S; Flegel WA; Hendrickson JE; Tormey CA
Br J Haematol; 2020 Dec; 191(5):653-657. PubMed ID: 32738068
[No Abstract] [Full Text] [Related]
36. Guidelines on gamma irradiation of blood components for the prevention of transfusion-associated graft-versus-host disease. BCSH Blood Transfusion Task Force.
Transfus Med; 1996 Sep; 6(3):261-71. PubMed ID: 8885157
[No Abstract] [Full Text] [Related]
37. Graft-versus-host disease in a liver transplant recipient.
Collins RH; Cooper B; Nikaein A; Klintmalm G; Fay JW
Ann Intern Med; 1992 Mar; 116(5):391-2. PubMed ID: 1736772
[No Abstract] [Full Text] [Related]
38. Graft-versus-host disease.
Petz LD
N Engl J Med; 1993 Aug; 329(9):664-5. PubMed ID: 8341353
[No Abstract] [Full Text] [Related]
39. Developments in the prevention of transfusion-associated graft-versus-host disease.
Fast LD
Br J Haematol; 2012 Sep; 158(5):563-8. PubMed ID: 22734439
[TBL] [Abstract][Full Text] [Related]
40. The use of leukocyte-reduced blood components.
Miller JP; Mintz PD
Hematol Oncol Clin North Am; 1995 Feb; 9(1):69-90. PubMed ID: 7737945
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
